Literature DB >> 18416567

Global changes in and characterization of specific sites of phosphorylation in mouse and human histone H1 Isoforms upon CDK inhibitor treatment using mass spectrometry.

Leesa J Deterding1, Maureen K Bunger, Geoffrey C Banks, Kenneth B Tomer, Trevor K Archer.   

Abstract

Global changes in the phosphorylation state of human H1 isoforms isolated from UL3 cells have been investigated using mass spectrometry. Relative changes in H1 phosphorylation between untreated cells and cells treated with dexamethasone or various CDK inhibitors were determined. The specific cyclin-dependent kinase consensus sites of phosphorylation on the histone H1 isoforms that show changes in phosphorylation were also investigated. Three sites of phosphorylation on histone H1.4 isoforms have been identified.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18416567      PMCID： PMC2761089          DOI： 10.1021/pr700790a

Source DB:  PubMed          Journal:  J Proteome Res        ISSN： 1535-3893            Impact factor:   5.370


  42 in total

1.  Phosphorylation of linker histone H1 regulates gene expression in vivo by mimicking H1 removal.

Authors:  Y Dou; C A Mizzen; M Abrams; C D Allis; M A Gorovsky
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

Review 2.  Histone H1 diversity: bridging regulatory signals to linker histone function.

Authors:  S Khochbin
Journal:  Gene       Date:  2001-06-13       Impact factor: 3.688

3.  Mass spectrometric mapping of linker histone H1 variants reveals multiple acetylations, methylations, and phosphorylation as well as differences between cell culture and tissue.

Authors:  Jacek R Wisniewski; Alexandre Zougman; Sonja Krüger; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2006-10-15       Impact factor: 5.911

4.  Phosphorylation of linker histones by a protein kinase A-like activity in mitotic nuclei.

Authors:  M T Sweet; G Carlson; R G Cook; D Nelson; C D Allis
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

5.  The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.

Authors:  Chunrong Yu; Mohamed Rahmani; Yun Dai; Daniel Conrad; Geoffrey Krystal; Paul Dent; Steven Grant
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

6.  Mouse oocytes and early embryos express multiple histone H1 subtypes.

Authors:  Germaine Fu; Parinaz Ghadam; Allen Sirotkin; Saadi Khochbin; Arthur I Skoultchi; Hugh J Clarke
Journal:  Biol Reprod       Date:  2002-12-11       Impact factor: 4.285

7.  CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation.

Authors:  E E Brooks; N S Gray; A Joly; S S Kerwar; R Lum; R L Mackman; T C Norman; J Rosete; M Rowe; S R Schow; P G Schultz; X Wang; M M Wick; D Shiffman
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

8.  The dynamic mobility of histone H1 is regulated by cyclin/CDK phosphorylation.

Authors:  Alejandro Contreras; Tracy K Hale; David L Stenoien; Jeffrey M Rosen; Michael A Mancini; Rafael E Herrera
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

9.  Understanding global changes in histone H1 phosphorylation using mass spectrometry.

Authors:  Leesa J Deterding; Geoffrey C Banks; Kenneth B Tomer; Trevor K Archer
Journal:  Methods       Date:  2004-05       Impact factor: 3.608

10.  Phosphorylation and an ATP-dependent process increase the dynamic exchange of H1 in chromatin.

Authors:  Yali Dou; Josephine Bowen; Yifan Liu; Martin A Gorovsky
Journal:  J Cell Biol       Date:  2002-09-30       Impact factor: 10.539
View more
  11 in total

Review 1.  The H1 linker histones: multifunctional proteins beyond the nucleosomal core particle.

Authors:  Sonja P Hergeth; Robert Schneider
Journal:  EMBO Rep       Date:  2015-10-15       Impact factor: 8.807

Review 2.  Histone phosphorylation: a chromatin modification involved in diverse nuclear events.

Authors:  Dorine Rossetto; Nikita Avvakumov; Jacques Côté
Journal:  Epigenetics       Date:  2012-09-04       Impact factor: 4.528

3.  Histone modifiers in cancer: friends or foes?

Authors:  Idan Cohen; Elżbieta Poręba; Kinga Kamieniarz; Robert Schneider
Journal:  Genes Cancer       Date:  2011-06

Review 4.  Chromatin higher-order structures and gene regulation.

Authors:  Guohong Li; Danny Reinberg
Journal:  Curr Opin Genet Dev       Date:  2011-02-20       Impact factor: 5.578

5.  Assaying pharmacodynamic endpoints with targeted therapy: flavopiridol and 17AAG induced dephosphorylation of histone H1.5 in acute myeloid leukemia.

Authors:  Liwen Wang; Sean W Harshman; Shujun Liu; Chen Ren; Hua Xu; Larry Sallans; Michael Grever; John C Byrd; Guido Marcucci; Michael A Freitas
Journal:  Proteomics       Date:  2010-12       Impact factor: 3.984

6.  An IGF1/insulin receptor substrate-1 pathway stimulates a mitotic kinase (cdk1) in the uterine epithelium during the proliferative response to estradiol.

Authors:  Michael P Walker; Richard P Diaugustine; Ernest Zeringue; Maureen K Bunger; Martina Schmitt; Trevor K Archer; R Gregg Richards
Journal:  J Endocrinol       Date:  2010-08-26       Impact factor: 4.286

7.  Alterations of histone H1 phosphorylation during bladder carcinogenesis.

Authors:  Kelly H Telu; Besma Abbaoui; Jennifer M Thomas-Ahner; Debra L Zynger; Steven K Clinton; Michael A Freitas; Amir Mortazavi
Journal:  J Proteome Res       Date:  2013-06-17       Impact factor: 4.466

8.  Site-specific regulation of histone H1 phosphorylation in pluripotent cell differentiation.

Authors:  Ruiqi Liao; Craig A Mizzen
Journal:  Epigenetics Chromatin       Date:  2017-05-22       Impact factor: 4.954

Review 9.  Mass spectrometry-based characterization of histones in clinical samples: applications, progress, and challenges.

Authors:  Roberta Noberini; Giulia Robusti; Tiziana Bonaldi
Journal:  FEBS J       Date:  2021-01-23       Impact factor: 5.622

Review 10.  H1 histones: current perspectives and challenges.

Authors:  Sean W Harshman; Nicolas L Young; Mark R Parthun; Michael A Freitas
Journal:  Nucleic Acids Res       Date:  2013-08-14       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.